Aids: Society, Ethics and Law

Cover
Half Title
Title Page
Copyright Page
Table of Contents
Acknowledgements
Series Preface
Introduction
Part I The Physician-Patient Relationship
	Duty to Treat
		1 George J. Annas (1988), ‘Legal Risks and Responsibilities of Physicians in the AIDS Epidemic’, Hastings Center Report, April/May, pp. 26-32
		2 Norman Daniels (1991), ‘Duty to Treat or Right to Refuse?’, Hastings Center Report, March/April, pp. 36-46
		3 Doran Smolkin (1997), ‘HIV Infection, Risk Taking, and the Duty to Treat’, Journal of Medicine and Philosophy, 22, pp. 55-74
	Confidentiality/Privacy
		4 Gary B. Melton (1988), ‘Ethical and Legal Issues in AIDS-Related Practice’, American Psychologist, 43, pp. 941-47
		5 Kenneth M. Boyd (1992), ‘HIV Infection and AIDS: The Ethics of Medical Confidentiality’, Journal of Medical Ethics, 18, pp. 173-79
	Infected Health Care Workers
		6 Patti Miller Tereskerz, Richard D. Pearson and Janine Jagger (1999), ‘Infected Physicians and Invasive Procedures: National Policy and Legal Reality’, The Milbank Quarterly, 77, pp. 511-29
		7 Karen C. Lieberman and Arthur R. Derse (1992), ‘HIV-Positive Health Care Workers and the Obligation to Disclose: Do Patients Have a Right to Know?’, Journal of Legal Medicine, 13, pp. 333-56
Part II Aids and the Law
	8 Larry Gostin (1989), ‘The Politics of AIDS: Compulsory State Powers, Public Health, and Civil Liberties’, Ohio State Law Journal, 49, pp. 1017-58
	9 Richard D. Mohr (1987), ‘AIDS, Gays, and State Coercion’, Bioethics, 1, pp. 35-50
	10 Alistair Orr (1989), ‘Legal AIDS: Implications of AIDS and HIV for British and American Law’, Journal of Medical Ethics, 15, pp. 61-67
	11 Helen Power (1997), ‘HIV/AIDS, Sex and the Criminal Law’, Journal of Social Welfare and Family Law, 19, pp. 343-51
	12 Editor (1998), ‘Second International Consultation on HIV/AIDS and Human Rights Adopts International Guidelines’, International Digest of Health Legislation, 49, pp. 703-6
Part III HIV Testing
	General
		13 G.R. McLean and T. Jenkins (1994), ‘HIV Testing and Informed Consent - Ethical Considerations’, South African Medical Journal (SAMJ), 84, pp. 669-74
		14 Martin Gunderson, David Mayo and Frank Rhame (1996), ‘Routine HIV Testing of Hospital Patients and Pregnant Women: Informed Consent in the Real World’, Kennedy Institute of Ethics Journal, 6, pp. 161-82
	Pregnant Women
		15 Quarraisha Abdool Karim, Salim S. Abdool Karim, Hoosen M. Coovadia and Mervyn Susser (1998), ‘Informed Consent for HIV Testing in a South African Hospital: Is It Truly Informed and Truly Voluntary?’, American Journal of Public Health, 88, pp. 637-40
		16 Theresa M. McGovern (1997), ‘Mandatory HIV Testing and Treating of Child-Bearing Women: An Unnatural, Illegal, and Unsound Approach’, Columbia Human Rights Law Review, 28, pp. 469-99
Part IV Clinical Research
	General
		17 Joni N. Gray and Gary B. Melton (1985), ‘The Law and Ethics of Psychosocial Research on AIDS’, Nebraska Law Review, 64, pp. 637-88
		18 Wendy K. Mariner (1990), ‘The Ethical Conduct of Clinical Trials of HIV Vaccines’, Evaluation Review, 14, pp. 538-64
		19 Nancy E. Kass, Holly A. Taylor and Patricia A. King (1996), ‘Harms of Excluding Pregnant Women from Clinical Research: The Case of HIV-Infected Pregnant Women’, Journal of Law, Medicine & Ethics, 24, pp. 36-46
		20 John D. Arras (1990), ‘Noncompliance in AIDS Research’, Hastings Center Report, September/October, pp. 24-32
	Community Consultation
		21 Gary B. Melton, Robert J. Levine, Gerald P. Koocher, Robert Rosenthal and William C. Thompson (1988), ‘Community Consultation in Socially Sensitive Research: Lessons from Clinical Trials of Treatments for AIDS’, American Psychologist, 43, pp. 573-81
		22 Herbert R. Spiers (1991), ‘Community Consultation and AIDS Clinical Trials, Parts 1-3’, IRB: A Review of Human Subjects Research, 13, May-June, pp. 7-10, July-August, pp. 1-6, September-October, pp. 3-7
		23 Joan E. Sieber and James L. Sorensen (1992), ‘Conducting Social and Behavioral AIDS Research in Drug Treatment Clinics’, IRB: A Review of Human Subjects Research, 14, September-October, pp. 1-5
	Developing Countries
		24 Peter Lurie and Sidney M. Wolfe (1997), ‘Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries’, New England Journal of Medicine, 337, pp. 853-56
		25 Harold Varmus and David Satcher (1997), ‘Ethical Complexities of Conducting Research in Developing Countries’, New England Journal of Medicine, 337, pp. 1003-5
		26 George J. Annas and Michael A. Grodin (1998), ‘Human Rights and Maternal-Fetal HIV Transmission Prevention Trials in Africa’, American Journal of Public Health, 88, pp. 560-63
		27 Robert J. Levine (1998), ‘The “Best Proven Therapeutic Method” Standard in Clinical Trials in Technologically Developing Countries’, IRB: A Review of Human Subjects Research, 20, January-February, pp. 5-9
		28 Peter Lurie, Makonnen Bishaw, Margaret A. Chesney, Molly Cooke, Maria Eugenia Lemos Fernandes, Norman Hearst, Edward Katongole-Mbidde, Suporn Koetsawang, Christina P. Lindan, Jeffrey Mandel, Marvellous Mhloyi and Thomas J. Coates (1994), ‘Ethical, Behavioral, and Social Aspects of HIV Vaccine Trials in Developing Countries’, JAMA, 271, pp. 295-301
Part V Access to (Experimental) Drugs
	29 Ellen C. Cooper (1989), ‘Controlled Clinical Trials of AIDS Drugs: The Best Hope’, JAMA, 261, p. 2445
	30 Martin Delaney (1989), ‘The Case for Patient Access to Experimental Therapy’, The Journal of Infectious Diseases, 159, pp. 416-19
	31 Udo Schtiklenk and Carlton Hogan (1996), ‘Patient Access to Experimental Drugs and AIDS Clinical Trial Designs: Ethical Issues’, Cambridge Quarterly of Healthcare Ethics, 5, pp. 400-409
	32 Harold Edgar and David J. Rothman (1990), ‘New Rules for New Drugs: The Challenge of AIDS to the Regulatory Process’, The Milbank Quarterly, 68, (Supplement 1), pp. 111-42
	33 David A. Salisbury and Martin T. Schechter (1990), ‘AIDS Trials, Civil Liberties and the Social Control of Therapy: Should we Embrace New Drugs with Open Arms?’, Canadian Medical Association Journal, 142, pp. 1057-62
	34 Andrew F. Shorr (1992), ‘AIDS and the FDA: An Ethical Case for Limiting Patient Access to New Medical Therapies’, IRB: A Review of Human Subjects Research, 14, July-August, pp. 1-5
	35 David B. Resnik (2001), ‘Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma’, Developing World Bioethics, 1, pp. 11-32
	36 Dan W. Brock (2001), ‘Some Questions About the Moral Responsibilities of Drug Companies in Developing Countries’, Developing World Bioethics, 1, pp. 33-37
	37 Norman Daniels (2001), ‘Social Responsibility and Global Pharmaceutical Companies’, Developing World Bioethics, 1, pp. 38-41
Part VI Dying with Dignity
	38 Sophia Vinogradov, Joe T. Thornton, A-J. Rock Levinson and Michael L. Callen (1984), ‘If I Have AIDS, Then Let Me Die Now!’, Hastings Center Report, 14, pp. 24-26
	39 Margaret P. Battin (1994), ‘Going Early, Going Late: The Rationality of Decisions about Suicide in AIDS’, Journal of Medicine and Philosophy, 19, pp. 571—94
Name Index